Predicting stimulant medication response in ADHD: Evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors

Journal of Integrative Neuroscience

Volumn 4, Issue 1, 2005, Pages 107-121

  Hermens, Daniel F ^a   Cooper, Nicholas J ^b   Kohn, Michael ^a,c   Clarke, Simon ^a,c   Gordon, Evian ^a,b   Williams, Leanne M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Brain Resource Company   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Attention Deficit Hyperactivity Disorder (ADHD); Neuropsychology; Psychophysiology; Stimulant medication prediction

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; AUDITORY DISCRIMINATION; AUTONOMIC NERVOUS SYSTEM FUNCTION; BETA RHYTHM; BRAIN DEPTH STIMULATION; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; CLINICAL EXAMINATION; DOSE RESPONSE; FEMALE; HUMAN; MALE; MENTAL PERFORMANCE; MENTAL TASK; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PREDICTION; PSYCHOPHYSIOLOGY; QUESTIONNAIRE; SCHOOL CHILD; SYMPTOMATOLOGY; VISUAL DISCRIMINATION; VISUAL MEMORY; WORKING MEMORY;

ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DATA INTERPRETATION, STATISTICAL; DISCRIMINANT ANALYSIS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; GALVANIC SKIN RESPONSE; HUMANS; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHOMOTOR PERFORMANCE; PSYCHOPHYSIOLOGY;

EID: 18444416382     PISSN: 02196352     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0219635205000653     Document Type: Article

References (21)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th Ed., American Psychiatric Press, Washington, DC, 1994.
2. Barkley RA, Predicting the response of hyperkinetic children to stimulant drugs: A review, J Abnorm Child Psych 4:327-348, 1976.
3. Barry RJ, Johnstone SJ, Clarke AR, A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials, Clin Neurophysiol 114:184-198, 2003.
4. Berbatis CG, Sunderland VB, Bulsara M, Licit psychostimulant consumption in Australia, 1984-2000: International and jurisdictional comparison, Med J Australia 177:539-543, 2002.
5. Bresnahan SM, Anderson JW, Barry RJ, Age-related changes in quantitative EEG in attention-deficit/hyperactivity disorder, Biol Psychiat 46:1690-1697, 1999.
6. Buitelaar JK, van der Gaag RJ, Swaab-Barneveld H, Kuiper M, Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder, J Am Acad Child Psy 34(8):1025-32, 1995.
7. Chabot RJ, Orgill AA, Crawford G, Harris MJ, Serfontein G, Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders, J Child Neurol 14:343-351, 1999.
8. Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Excess beta activity in children with attention-deficit/hyperactivity disorder: An atypical electrophysiological group, Psychiat Res 103:205-218, 2001.
9. de Sonneville LM, Njiokiktjien C, Bos H, Methylphenidate and information processing. Part 1: Differentiation between responders and nonresponders; Part 2: Efficacy in responders, J Clin Exp Neuropsyc 16:877-897, 1994.
10. Denney CB, Rapport MD, Predicting methylphenidate response in children with ADHD: Theoretical, empirical, and conceptual models, J Am Acad Child Adolesc Psychiatry 38:93-401, 1999.
11. Efron D, Jarman F, Barker M, Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial, Pediatrics 100:662-666, 1997.
12. Elia J, Drug treatment for hyperactive children. Therapeutic guidelines, Drugs 46:863-871, 1993.
13. Faraone SV, Biederman J, Neurobiology of attention-deficit hyperactivity disorder, Biol Psychiat 44:951-958, 1998.
14. Gratton G, Coles MG, Donchin E, A new method for off-line removal of ocular artifact, Electroen Clin Neuro 55:468-484, 1983.
15. Konrad K, Gunther T, Hanisch C, Herpertz-Dahlmann B, Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry 43(2):191-8, 2004.
16. Riccio CA, Waldrop JJ, Reynolds CR, Lowe P, Effects of stimulants on the continuous performance test (CPT): Implications for CPT use and interpretation, J Neuropsych Clin N 13:26-335, 2001.
17. Sangal RB, Sangal JM, Attention-deficit/hyperactivity disorder: Cognitive evoked potential (P300) topography predicts treatment response to methylphenidate, Clin Neurophysiol 115(1):188-93, 2004.
18. Sawyer MG, Arney FM, Baghurst PA, Clark JJ, Graetz BW, Kosky RJ, Nurcombe B, Patton GC, Prior MR, Raphael B, Rey JM, Whaites LC, Zubrick SR, The mental health of young people in Australia: Key findings from the child and adolescent component of the national survey of mental health and well-being, Aust NZ J Psychiat 35:806-814, 2001.
19. Sawyer MG, Rey JM, Graetz BW, Clark JJ, Baghurst PA, Use of medication by young people with attention-deficit/hyperactivity disorder, Med J Australia 177:21-25, 2002.
20. Taylor E, Schachar R, Thorley G, Wieselberg HM, Everitt B, Rutter M, Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behavior, Psychol Med 17:121-143, 1987.
21. Thomson JB, Varley CK, Prediction of stimulant response in children with attention-deficit/hyperactivity disorder, J Child Adol Psychop 8:125-132, 1998.